全文获取类型
收费全文 | 737篇 |
免费 | 32篇 |
专业分类
耳鼻咽喉 | 5篇 |
儿科学 | 36篇 |
妇产科学 | 3篇 |
基础医学 | 62篇 |
口腔科学 | 41篇 |
临床医学 | 62篇 |
内科学 | 157篇 |
皮肤病学 | 56篇 |
神经病学 | 16篇 |
特种医学 | 28篇 |
外科学 | 113篇 |
综合类 | 22篇 |
预防医学 | 21篇 |
眼科学 | 27篇 |
药学 | 91篇 |
中国医学 | 1篇 |
肿瘤学 | 28篇 |
出版年
2024年 | 1篇 |
2023年 | 6篇 |
2022年 | 22篇 |
2021年 | 46篇 |
2020年 | 9篇 |
2019年 | 13篇 |
2018年 | 17篇 |
2017年 | 16篇 |
2016年 | 28篇 |
2015年 | 27篇 |
2014年 | 41篇 |
2013年 | 48篇 |
2012年 | 76篇 |
2011年 | 69篇 |
2010年 | 31篇 |
2009年 | 24篇 |
2008年 | 35篇 |
2007年 | 45篇 |
2006年 | 44篇 |
2005年 | 24篇 |
2004年 | 18篇 |
2003年 | 30篇 |
2002年 | 43篇 |
2001年 | 17篇 |
2000年 | 9篇 |
1999年 | 7篇 |
1998年 | 5篇 |
1997年 | 5篇 |
1996年 | 1篇 |
1991年 | 2篇 |
1990年 | 1篇 |
1989年 | 2篇 |
1986年 | 1篇 |
1985年 | 1篇 |
1984年 | 2篇 |
1983年 | 1篇 |
1980年 | 1篇 |
1978年 | 1篇 |
排序方式: 共有769条查询结果,搜索用时 31 毫秒
1.
Outcomes in patients with interrupted aortic arch and associated anomalies: a 20-year experience. 总被引:6,自引:0,他引:6
John W Brown Mark Ruzmetov Yuji Okada Palaniswamy Vijay Mark D Rodefeld Mark W Turrentine 《European journal of cardio-thoracic surgery》2006,29(5):666-73; discussion 673-4
OBJECTIVE: The surgical results for the repair of interrupted aortic arch (IAA) have evolved in recent years. We report our results for staged repair of this complex congenital malformation. METHODS: Sixty-five patients (mean age, 16.9+/-41.7 days) were diagnosed with IAA and referred for surgical therapy. The surgical management strategy at our institution between 1982 and 2005 has been one-stage complete repair (n=13) or staged repair (n=52) in selected patients. Non-complex patients (group I, n=51) had a ventricular septal defect (87%), aortopulmonary window (8%), and left ventricular outflow tract obstruction (27%). Group II (n=14) were patients with Taussig-Bing double outlet right ventricle (n=6) or truncus arteriosus (n=8). Method of staged repair of IAA was to transect and turn down the left carotid artery and anastomosis it to the descending aorta (n=41) or graft interposition (n=2) combined with a pulmonary artery (PA) banding followed in a few months by delayed ventricular septal defect (VSD) closure and PA de-banding. RESULTS: There were 5 early and 10 late deaths. The actuarial survival including early mortality was 92% at 1 year, 81% at 5 years, and 76% at 10 and 15 years. There was an 81% 15-year survival for children in group I compared with a 54% for children in group II (p<0.001). Risk factors for increased mortality by univariate analysis were as follows: (1) primary aortic anastomosis (p=0.03), (2) presence of complex anomalies (p=0.05), and (3) initial IAA repair performed before 1994 (p=0.05). Actuarial freedom from any type of aortic reoperation or intervention was 86% at 1 year, 69% at 5 years, and 60% at 10 and 15 years. Univariate and multivariate analyses identified no tested variables as risk factors for reoperation. The majority (86%) was in New York Heart Association (NYHA) class I, and 14% remained in NYHA class II. During the postoperative course there were no neurologic deficits, seizures, and growth disturbances in any patient. CONCLUSION: Staged repair of IAA using a left carotid artery turn down can be safely applied in IAA patients with and without other intracardiac anomalies with good results. Use of the left carotid artery for arch reconstruction did not result in any detectable neurological events or growth disturbances later in life. Associated anomalies played an important role in outcomes. The long-term probability for reoperation and/or reintervention remains high regardless of operative technique. 相似文献
2.
Bioavailability studies on guar gum-based three-layer matrix tablets of trimetazidine dihydrochloride in human volunteers. 总被引:1,自引:0,他引:1
Y S R Krishnaiah R S Karthikeyan P Bhaskar V Satyanarayana 《Journal of controlled release》2002,83(2):231-239
Guar gum-based three-layer matrix tablets of a highly water-soluble drug, trimetazidine dihydrochloride, were evaluated for their in vivo release in healthy volunteers in comparison with commercially available conventional immediate release tablets. Six healthy volunteers participated in the study and a two-way crossover design was followed. The plasma concentration of trimetazidine dihydrochloride was estimated by reverse-phase HPLC. The pharmacokinetic parameters were calculated from the plasma concentration of trimetazidine dihydrochloride versus time data. The delayed T(max), decreased C(max) and K(a), unaltered bioavailability, and prolonged t(1/2) and MRT indicated a slow and prolonged release of trimetazidine dihydrochloride from guar gum three-layer matrix tablets in comparison with the immediate release tablet dosage form. The guar gum three-layer matrix tablets of trimetazidine dihydrochloride may be useful in providing constant drug delivery with minimum fluctuations. 相似文献
3.
4.
5.
New approaches to preventing restenosis 总被引:1,自引:0,他引:1
Balram Bhargava Ganesan Karthikeyan Alexandre S Abizaid Roxana Mehran 《British medical journal》2003,327(7409):274-279
6.
S M Al-Saidan Y S R Krishnaiah V Satyanarayana P Bhaskar R S Karthikeyan 《European journal of pharmaceutics and biopharmaceutics》2004,58(3):697-703
The objective of the present study is to carry out pharmacokinetic evaluation of oral controlled release formulation (guar gum-based three-layer matrix tablets) containing highly soluble metoprolol tartrate as a model drug. Six healthy volunteers participated in the study, and a two-way crossover design was followed. The plasma concentration of metoprolol tartrate was estimated by reverse-phase HPLC. The pharmacokinetic parameters were calculated from the plasma concentration of metoprolol tartrate versus time data. The delayed T(max) lower C(max) decreased K(a) unaltered bioavailability and prolonged t(1/2) indicated a slow and prolonged release of metoprolol tartrate from guar gum three-layer matrix tablets in comparison with the immediate release tablet dosage form. The results of the study indicated that guar gum three-layer matrix tablets were able to provide oral controlled delivery of highly water-soluble drug such as metoprolol tartrate in humans. 相似文献
7.
8.
9.
10.